Find Dextrans manufacturers, exporters & distributors on PharmaCompass

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Virtual Booth

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

19 API Suppliers, 8 USDMF, 4 CEP/COS, 3 JDMF, 6 NDC API, 1 VMF, 5 Listed Suppliers

19 API Suppliers
8 USDMF
4 CEP/COS
3 JDMF
6 NDC API
1 VMF
5 Listed Suppliers

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers, 11 Europe, 6 Canada, 4 South Africa, 4 Listed Dossiers

25 FDF Dossiers
11 Europe
6 Canada
4 South Africa
4 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Evonik, 1 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 1 Faran Shimi Pharmaceutical, 1 Nanjing Well Pharmaceutical, 8 Actylis, 1 BASF, 3 Finar, 3 Gangwal Chemicals, 2 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pluviaendo, 4 Roquette, 6 Seppic

relatedExcipients
1 Evonik
1 SPI Pharma
1 DKSH
1 Jai Radhe Sales
1 Faran Shimi Pharmaceutical
1 Nanjing Well Pharmaceutical
8 Actylis
1 BASF
3 Finar
3 Gangwal Chemicals
2 Microlex e.U
1 Nanjing Bold Chemical
1 Pluviaendo
4 Roquette
6 Seppic

EXCIPIENTS BY APPLICATIONS

15 Parenteral, 12 Solubilizers, 5 Topical, 3 Fillers, Diluents & Binders, 3 Emulsifying Agents, 2 Film Formers & Plasticizers, 2 Surfactant & Foaming Agents, 2 API Stability Enhancers, 2 Thickeners and Stabilizers, 1 Controlled & Modified Release, 1 Direct Compression, 1 Co-Processed Excipients, 1 Rheology Modifiers, 1 Disintegrants & Superdisintegrants

excipientsByApplications
15 Parenteral
12 Solubilizers
5 Topical
3 Fillers, Diluents & Binders
3 Emulsifying Agents
2 Film Formers & Plasticizers
2 Surfactant & Foaming Agents
2 API Stability Enhancers
2 Thickeners and Stabilizers
1 Controlled & Modified Release
1 Direct Compression
1 Co-Processed Excipients
1 Rheology Modifiers
1 Disintegrants & Superdisintegrants

DIGITAL CONTENT

8 NEWS #PharmaBuzz

media
8 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

8 Finished Drug Prices

globalSalesInformation
8 Finished Drug Prices

MARKET PLACE

8 APIs, 2 FDF Dossiers, 1 EXCIPIENTS

marketPlace
8 APIs
2 FDF Dossiers
1 EXCIPIENTS

REF. STANDARDS & IMPURITIES

3 EDQM , 12 USP , 12 Others

otherSolutions
3 EDQM
12 USP
12 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

2DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

35 RELATED EXCIPIENT COMPANIES

51EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: L3l3xyp7mp, Lmwd, Schembl206877, Chembl1697742, O-alpha-d-glucopyranosyl-(1.6)-o-alpha-d-glucopyranosyl-(1.6)-d-glucose, Hy-n0913a

Molecular Formula

C₁₈H₃₂O₁₆

Molecular Weight

504.4 g/mol

InChI Key

FZWBNHMXJMCXLU-BLAUPYHCSA-N

FDA UNII

L3L3XYP7MP

A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes.

1 2D Structure

Dextrans

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2R,3S,4R,5R)-2,3,4,5-tetrahydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal

2.1.2 InChI

InChI=1S/C18H32O16/c19-1-5(21)9(23)10(24)6(22)3-31-17-16(30)14(28)12(26)8(34-17)4-32-18-15(29)13(27)11(25)7(2-20)33-18/h1,5-18,20-30H,2-4H2/t5-,6+,7+,8+,9+,10+,11+,12+,13-,14-,15+,16+,17-,18-/m0/s1

2.1.3 InChI Key

FZWBNHMXJMCXLU-BLAUPYHCSA-N

2.1.4 Canonical SMILES

C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(C=O)O)O)O)O)O)O)O)O)O)O)O

2.1.5 Isomeric SMILES

C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)OC[C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O)O)O)O)O)O)O

2.2 Other Identifiers

2.2.1 UNII

L3L3XYP7MP

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Dextran

2. Dextran 40000

3. Dextran 70

4. Dextran 75

5. Dextran 80

6. Dextran B 1355

7. Dextran B 1355 S

8. Dextran B-1355

9. Dextran B-1355-s

10. Dextran B1355

11. Dextran B512

12. Dextran Derivatives

13. Dextran M 70

14. Dextran T 40

15. Dextran T 500

16. Dextran T 70

17. Dextran T-40

18. Dextran T-500

19. Dextrans

20. Hemodex

21. Hyskon

22. Infukoll

23. Macrodex

24. Polyglucin

25. Promit

26. Rheodextran

27. Rheoisodex

28. Rheomacrodex

29. Rheopolyglucin

30. Rondex

31. Saviosol

2.3.2 Depositor-Supplied Synonyms

1. L3l3xyp7mp

2. Lmwd

3. Schembl206877

4. Chembl1697742

5. O-alpha-d-glucopyranosyl-(1.6)-o-alpha-d-glucopyranosyl-(1.6)-d-glucose

6. Hy-n0913a

7. Dtxsid701317190

8. 6-.alpha.-isomaltosylglucose

9. Zinc64622163

10. Cs-0109495

11. D-glucose, O-.alpha.-d-glucopyranosyl-(1->6)-o-.alpha.-d-glucopyranosyl-(1->6)-

12. O-alpha-d-glucopyranosyl-(1-->6)-o-alpha-d-glucopyranosyl-(1-->6)-d-glucose

13. Wurcs=2.0/2,3,2/[o2122h][a2122h-1a_1-5]/1-2-2/a6-b1_b6-c1

14. (2r,3s,4r,5r)-2,3,4,5-tetrahydroxy-6-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)methyl)oxan-2-yl)oxy)hexanal

2.4 Create Date

2004-09-16

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₃₂O₁₆
Molecular Weight	504.4 g/mol
XLogP3	-7.2
Hydrogen Bond Donor Count	11
Hydrogen Bond Acceptor Count	16
Rotatable Bond Count	11
Exact Mass	504.16903493 g/mol
Monoisotopic Mass	504.16903493 g/mol
Topological Polar Surface Area	277 Å²
Heavy Atom Count	34
Formal Charge	0
Complexity	625
Isotope Atom Count	0
Defined Atom Stereocenter Count	14
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Anticoagulants

Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)

Plasma Substitutes

Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used to treat dehydration. (See all compounds classified as Plasma Substitutes.)

4.2 FDA Pharmacological Classification

4.2.1 Pharmacological Classes

Osmotic Activity [MoA]; Plasma Volume Expander [EPC]; Increased Intravascular Volume [PE]

API SUPPLIERS